Pharmacological and Molecular Perspective on Diabetes is a book devoted to publishing the latest and the most important advances in anti-diabetic drugs and their associated complications. Eminent researchers and scientists have contributed chapters focused on all areas of rational pharmacological and molecular perspectives associated with diabetes mellitus. This book should prove to be of interest to all pharmaceutical and molecular scientists who are involved in research in drug design and discovery especially associated with diabetes and who wish to keep abreast of rapid and important developments in the field.
Topics included in this book are:
• Epigenetic Alterations and Type 2 Diabetes Mellitus
• Responses to nutritional chromium supplements for Type 2 Diabetes Mellitus
• Endocrine Role of Osteocalcin in Homeostatic Regulation of Glucose Metabolism
• Effect of diabetes on memory
• Osteoarthritis in relation to type II diabetes mellitus: Prevalence, etiology, symptoms and molecular mechanism
• Infection of novel Coronavirus in Patients with Diabetes mellitus
• Role of an Anti-Inflammatory agent in the management of Type 2 Diabetes Mellitus
• Role ofantidiabetic agents which helps regulates TCF7L2 variations in Type 2 Diabetes Mellitus
• Relationship between Type 2 Diabetes Mellitus, PCOD and Neurological Disorders: Role of Antidiabetic Drugs
• Comparision of different types of insulin available for Type I Diabetes treatment
• Circadian Rhythm Disruption: Special Reference to Type 2 Diabetes Mellitus
• Type 2 Diabetes Mellitus and its Complications: Pharmacogenetics Based Correlations and Circulating MicroRNA as Biomarkers
Key features:
Pharmacological and Molecular Perspective on Diabetes is a book devoted to publishing the latest and the most important advances in anti-diabetic drugs and their associated complications. Eminent researchers and scientists have contributed chapters focused on all areas of rational pharmacological and molecular perspectives associated with diabetes mellitus. This book should prove to be of interest to all pharmaceutical and molecular scientists who are involved in research in drug design and discovery especially associated with diabetes and who wish to keep abreast of rapid and important developments in the field.
About the editor
Dr. Madhukar Saxena, Senior Researcher in Department of Biotechnology, Babasaheb Bhimrao Ambedkar University, Lucknow, India. He has published many national and international publications in the field of molecular biology, biochemistry, clinical genetics and stem cell biology of type 2 diabetes mellitus. He is also the author, editor and co-editor of many publications of international repute. He received prestigious grants from Department of Science and Technology, University Grant Commission and Indian Council of Medical Research, New Delhi. He has received best Young Scientist Award from Zoological Society of India and S.C. Pant Memorial Award from Society of Professional Biotechnologist, India. Dr. Madhukar is working in the field of adipocyte biology in relation to Diabetes Mellitus.
Keywords:
Diabetes Medication, diabetology, endocrinology of diabetes, Leptin, Metformin, Complications of Diabetes, Anti-Diabetic Drugs, Pioglitazone, WNT Signaling, Visfatin, Circadian Rhythms.
For more information, please visit: https://bit.ly/3L8NMk7